1,28,70,000(75.0%)
42,90,000(25.0%)
1,71,60,000
Sopan Pharmaceuticals Limited (SOPL) is listed under "Manufacturing And Processing" sector at Nepal Stock Exchange (NEPSE) on June 05, 2026 with a market capitalization of NPR 10,55,34,00,000 (10.6 Arab) and a float market capitalization of NPR 2,63,83,50,000 (2.6 Arab). It has a total of 1,71,60,000 (1.7 Crore) listed shares, of which 1,28,70,000 (1.3 Crore) (75%) are promoter shares and 42,90,000 (42.9 Lakh) (25%) are public shares.
By market capitalization, Sopan Pharmaceuticals Limited (SOPL) ranks #14 of 18 actively traded Manufacturing And Processing companies on NEPSE.
Sopan Pharmaceuticals Limited (SOPL) has a total market capitalization of NPR 10,55,34,00,000 (10.6 Arab) and a float market capitalization of NPR 2,63,83,50,000 (2.6 Arab). The book value stands at 121.41, resulting in a price-to-book value (PBV) of 5.07. The face value of each share is Rs. 100.
A total of 1,71,60,000 (1.7 Crore) shares of Sopan Pharmaceuticals Limited (SOPL) are listed in NEPSE, of which 1,28,70,000 (1.3 Crore) (75%) are promoter shares and 42,90,000 (42.9 Lakh) (25%) are public shares.
As of October 16, 2026, the latest trading price (LTP) of Sopan Pharmaceuticals Limited (SOPL) is Rs. 615 (15, 2.5%). Today, the stock opened at Rs. 600, reached a high of Rs. 615, and a low of Rs. 600. The previous closing price was Rs. 600, with a turnover of Rs. 9318986.5 and a trading volume of 15208 shares across 275 trades.
Over the past year, Sopan Pharmaceuticals Limited (SOPL) has seen a 52-week high of Rs. 1217 and a low of Rs. 276.5. The all-time high was Rs. 1217 on June 22, 2026, while the all-time low was Rs. 276.5 on June 08, 2026. The 120-day average price is Rs. 761.5, and the 180-day average is Rs. 761.5. The 1-year yield is currently 102.24%.
Sopan Pharmaceuticals Limited (SOPL) has an earnings per share (EPS) of 2.23 and a P/E ratio of 275.78. The book value per share is 121.41, and the price-to-book value (PBV) is 5.07. The stock's 1-year yield is 102.24%, and its fiscal year data is reported for 082-083, Q4. The paid-up capital is Rs. 1,71,60,00,000.
Sopan Pharmaceuticals Limited (SOPL) was listed on the Nepal Stock Exchange (NEPSE) on June 05, 2026 under the Manufacturing And Processing sector.
By market capitalization, Sopan Pharmaceuticals Limited (SOPL) ranks #14 of 18 actively traded Manufacturing And Processing companies listed on NEPSE. Its last traded price of Rs 615 sits at about 36% of the way between its 52-week low of Rs 276.5 and 52-week high of Rs 1217.
The promoter unlocking date for Sopan Pharmaceuticals Limited (SOPL) is on April 30, 2029. This date marks the end of the lock-in period for the company's promoter (eligible promoters, local people, employees etc.) shares, allowing promoters to trade them freely on the stock exchange.
